Skip to main content
Top
Published in: Journal of Nuclear Cardiology 2/2012

01-04-2012 | Review Article

PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation

Author: Henry Gewirtz, MD

Published in: Journal of Nuclear Cardiology | Issue 2/2012

Login to get access

Abstract

Considerable awareness has been raised of late of the need to reduce radiation exposure and control costs of x-ray and radionuclide imaging procedures. PET/CT cameras are now widely available and in conjunction with appropriate radionuclides and commercially available software make quantitative measurement of absolute MBF feasible for routine clinical practice. Quantitative measurement of absolute MBF under condition of coronary vasodilation permits independent assessment of the functional status of each of the three major coronary perfusion zones and so obviates the need for rest MBF determination in the great majority of cases. Coronary microvascular function also may be assessed in this same way. Thus, the stress-only protocol with quantitative PET measurement of MBF provides essential information required for clinical decision making related to need for catheterization and intervention for patients with known or suspected ischemic heart disease. Moreover, the single PET determination of maximal MBF in contrast to the usual rest/stress procedure addresses both safety and cost concerns. The present review focuses on: (1) quantitative PET measurements of myocardial blood flow for physiological assessment of the coronary circulation and (2) the value and potential limitations of performing stress only imaging in the clinical context.
Literature
1.
go back to reference Beller GA, Ragosta M. Decision making in multivessel coronary disease: The need for physiological lesion assessment. JACC Cardiovasc Interv 2010;3:315-7.PubMedCrossRef Beller GA, Ragosta M. Decision making in multivessel coronary disease: The need for physiological lesion assessment. JACC Cardiovasc Interv 2010;3:315-7.PubMedCrossRef
3.
go back to reference Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse [see comments]. Circulation 1998;98:1291-6.PubMedCrossRef Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse [see comments]. Circulation 1998;98:1291-6.PubMedCrossRef
4.
go back to reference Tawakol A, Forgione MA, Stuehlinger M, et al. Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol 2002;40:1051-8.PubMedCrossRef Tawakol A, Forgione MA, Stuehlinger M, et al. Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol 2002;40:1051-8.PubMedCrossRef
5.
go back to reference Gewirtz H. Cardiac PET: A versatile, quantitative measurement tool for heart failure management. JACC Cardiovasc Imaging 2011;4:292-302.PubMedCrossRef Gewirtz H. Cardiac PET: A versatile, quantitative measurement tool for heart failure management. JACC Cardiovasc Imaging 2011;4:292-302.PubMedCrossRef
6.
go back to reference El Fakhri G, Kardan A, Sitek A, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: Comparison with (13)N-ammonia PET. J Nucl Med 2009;50:1062-71.PubMedCrossRef El Fakhri G, Kardan A, Sitek A, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: Comparison with (13)N-ammonia PET. J Nucl Med 2009;50:1062-71.PubMedCrossRef
7.
go back to reference Nekolla SG, Reder S, Saraste A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: Comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-42.PubMedCrossRef Nekolla SG, Reder S, Saraste A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: Comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-42.PubMedCrossRef
8.
go back to reference Gewirtz H. Flurpiridaz F18, a PET myocardial perfusion imaging agent that binds electron transport complex 1. Thomson Reuters Pharma 2011;2011:1-12. Gewirtz H. Flurpiridaz F18, a PET myocardial perfusion imaging agent that binds electron transport complex 1. Thomson Reuters Pharma 2011;2011:1-12.
9.
go back to reference Gewirtz H, Fischman AJ, Abraham SA, et al. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994;23:851-9.PubMedCrossRef Gewirtz H, Fischman AJ, Abraham SA, et al. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994;23:851-9.PubMedCrossRef
10.
go back to reference Tawakol A, Skopicki HA, Abraham SA, et al. Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy. J Am Coll Cardiol 2000;36:2146-53.PubMedCrossRef Tawakol A, Skopicki HA, Abraham SA, et al. Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy. J Am Coll Cardiol 2000;36:2146-53.PubMedCrossRef
11.
go back to reference Mills I, Fallon JT, Wrenn D, et al. Adaptive responses of the coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol 1994;266:H447-57.PubMed Mills I, Fallon JT, Wrenn D, et al. Adaptive responses of the coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol 1994;266:H447-57.PubMed
12.
go back to reference Gerber BL, Vanoverschelde JJ, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.PubMedCrossRef Gerber BL, Vanoverschelde JJ, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.PubMedCrossRef
13.
go back to reference Canty JM Jr, Fallavollita JA. Chronic hibernation and chronic stunning: A continuum. J Nucl Cardiol 2000;7:509-27.PubMedCrossRef Canty JM Jr, Fallavollita JA. Chronic hibernation and chronic stunning: A continuum. J Nucl Cardiol 2000;7:509-27.PubMedCrossRef
14.
go back to reference Fallavollita JA, Logue M, Canty JM Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: Absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol 2001;37:1989-95.PubMedCrossRef Fallavollita JA, Logue M, Canty JM Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: Absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol 2001;37:1989-95.PubMedCrossRef
15.
16.
go back to reference Gould KL. Coronary flow reserve and pharmacologic stress perfusion imaging: Beginnings and evolution. JACC Cardiovasc Imaging 2009;2:664-9.PubMedCrossRef Gould KL. Coronary flow reserve and pharmacologic stress perfusion imaging: Beginnings and evolution. JACC Cardiovasc Imaging 2009;2:664-9.PubMedCrossRef
17.
go back to reference Gregory SA, MacRae CA, Aziz K, et al. Myocardial blood flow and oxygen consumption in patients with Friedreich’s ataxia prior to the onset of cardiomyopathy. Coron Artery Dis 2007;18:15-22.PubMedCrossRef Gregory SA, MacRae CA, Aziz K, et al. Myocardial blood flow and oxygen consumption in patients with Friedreich’s ataxia prior to the onset of cardiomyopathy. Coron Artery Dis 2007;18:15-22.PubMedCrossRef
18.
go back to reference Sdringola S, Johnson NP, Kirkeeide RL, Cid E, Gould KL. Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers. JACC Cardiovasc Imaging 2011;4:402-12.PubMedCrossRef Sdringola S, Johnson NP, Kirkeeide RL, Cid E, Gould KL. Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers. JACC Cardiovasc Imaging 2011;4:402-12.PubMedCrossRef
19.
go back to reference Seiler C, Fleisch M, Meier B. Direct intracoronary evidence of collateral steal in humans. Circulation 1997;96:4261-7.PubMedCrossRef Seiler C, Fleisch M, Meier B. Direct intracoronary evidence of collateral steal in humans. Circulation 1997;96:4261-7.PubMedCrossRef
20.
go back to reference Holmvang G, Fry S, Skopicki HA, et al. Relation between coronary “steal” and contractile function at rest in collateral-dependent myocardium of humans with ischemic heart disease. Circulation 1999;99:2510-6.PubMedCrossRef Holmvang G, Fry S, Skopicki HA, et al. Relation between coronary “steal” and contractile function at rest in collateral-dependent myocardium of humans with ischemic heart disease. Circulation 1999;99:2510-6.PubMedCrossRef
21.
go back to reference Skopicki HA, Abraham SA, Picard MH, et al. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation 1997;96:3346-52. [published erratum appears in Circulation 97:414].PubMedCrossRef Skopicki HA, Abraham SA, Picard MH, et al. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation 1997;96:3346-52. [published erratum appears in Circulation 97:414].PubMedCrossRef
22.
go back to reference Demer L, Gould K, Kirkeeide R. Assessing stenosis severity: Coronary flow reserve, collateral function, quantitative coronary arteriography, positron imaging, and digital subtraction angiography. A review and analysis. Prog in Cardiovasc Dis 1988;30:307-22.CrossRef Demer L, Gould K, Kirkeeide R. Assessing stenosis severity: Coronary flow reserve, collateral function, quantitative coronary arteriography, positron imaging, and digital subtraction angiography. A review and analysis. Prog in Cardiovasc Dis 1988;30:307-22.CrossRef
23.
go back to reference Gewirtz H, Gross SL, Williams DO, Most AS. Contrasting effects of nifedipine and adenosine on regional myocardial flow distribution and metabolism distal to a severe coronary arterial stenosis: Observations in sedated, closed-chest, domestic swine. Circulation 1984;69:1048-57.PubMedCrossRef Gewirtz H, Gross SL, Williams DO, Most AS. Contrasting effects of nifedipine and adenosine on regional myocardial flow distribution and metabolism distal to a severe coronary arterial stenosis: Observations in sedated, closed-chest, domestic swine. Circulation 1984;69:1048-57.PubMedCrossRef
24.
go back to reference Hajjiri MM, Leavitt MB, Zheng H, et al. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging 2009;2:751-8.PubMedCrossRef Hajjiri MM, Leavitt MB, Zheng H, et al. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging 2009;2:751-8.PubMedCrossRef
25.
go back to reference Kajander S, Joutsiniemi E, Saraste M, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 2010;122:603-13.PubMedCrossRef Kajander S, Joutsiniemi E, Saraste M, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 2010;122:603-13.PubMedCrossRef
26.
go back to reference Kajander SA, Joutsiniemi E, Saraste M, et al. Clinical value of absolute quantification of myocardial perfusion with 15O-water in coronary artery disease. Circ Cardiovasc Imaging 2011;4:678-84.PubMedCrossRef Kajander SA, Joutsiniemi E, Saraste M, et al. Clinical value of absolute quantification of myocardial perfusion with 15O-water in coronary artery disease. Circ Cardiovasc Imaging 2011;4:678-84.PubMedCrossRef
27.
go back to reference Gould KL, Nakagawa Y, Nakagawa K, et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography. Circulation 2000;101:1931-9.PubMedCrossRef Gould KL, Nakagawa Y, Nakagawa K, et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography. Circulation 2000;101:1931-9.PubMedCrossRef
28.
go back to reference De Bruyne B, Baudhum T, Melin JA, et al. Coronary flow reserve calculated from pressure measurements in humans: Validation with positron emission tomography. Circulation 1994;89:1013-22.PubMedCrossRef De Bruyne B, Baudhum T, Melin JA, et al. Coronary flow reserve calculated from pressure measurements in humans: Validation with positron emission tomography. Circulation 1994;89:1013-22.PubMedCrossRef
29.
go back to reference Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-8.PubMedCrossRef Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-8.PubMedCrossRef
30.
go back to reference Pijls NHJ, Van Gelder B, Van der Voort P, et al. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183-93.PubMedCrossRef Pijls NHJ, Van Gelder B, Van der Voort P, et al. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183-93.PubMedCrossRef
31.
go back to reference Marcus ML, Chilian WM, Kanatsuka H, et al. Understanding the coronary circulation through studies at the microvascular level. Circulation 1990;82:1-7.PubMedCrossRef Marcus ML, Chilian WM, Kanatsuka H, et al. Understanding the coronary circulation through studies at the microvascular level. Circulation 1990;82:1-7.PubMedCrossRef
32.
go back to reference De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995;92:39-46.PubMedCrossRef De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995;92:39-46.PubMedCrossRef
33.
go back to reference Miller DD, Donohue TJ, Younis LT, et al. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-60.PubMedCrossRef Miller DD, Donohue TJ, Younis LT, et al. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-60.PubMedCrossRef
34.
go back to reference Bartunek J, Marwick TH, Rodrigues AC, et al. Dobutamine-induced wall motion abnormalities: Correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol 1996;27:1429-36.PubMedCrossRef Bartunek J, Marwick TH, Rodrigues AC, et al. Dobutamine-induced wall motion abnormalities: Correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol 1996;27:1429-36.PubMedCrossRef
35.
36.
go back to reference Legalery P, Schiele F, Seronde MF, et al. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J 2005;26:2623-9.PubMedCrossRef Legalery P, Schiele F, Seronde MF, et al. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. Eur Heart J 2005;26:2623-9.PubMedCrossRef
37.
go back to reference Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-84.PubMedCrossRef Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-84.PubMedCrossRef
38.
go back to reference Melikian N, De Bondt P, Tonino P, et al. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv 2010;3:307-14.PubMedCrossRef Melikian N, De Bondt P, Tonino P, et al. Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv 2010;3:307-14.PubMedCrossRef
39.
go back to reference Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-11.PubMedCrossRef Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-11.PubMedCrossRef
40.
go back to reference Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.PubMedCrossRef Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.PubMedCrossRef
41.
go back to reference Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21.PubMedCrossRef Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21.PubMedCrossRef
42.
go back to reference Fedele FA, Sharaf B, Most AS, Gewirtz H. Details of coronary stenosis morphology influence its hemodynamic severity and distal flow reserve. Circulation 1989;80:636-42.PubMedCrossRef Fedele FA, Sharaf B, Most AS, Gewirtz H. Details of coronary stenosis morphology influence its hemodynamic severity and distal flow reserve. Circulation 1989;80:636-42.PubMedCrossRef
43.
go back to reference Gould K, Ornish D, Kirkeeide R, et al. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 1992;69:845-53.PubMedCrossRef Gould K, Ornish D, Kirkeeide R, et al. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 1992;69:845-53.PubMedCrossRef
44.
go back to reference Wykrzykowska JJ, Garg S, Girasis C, et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol 2010;56:272-7.PubMedCrossRef Wykrzykowska JJ, Garg S, Girasis C, et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol 2010;56:272-7.PubMedCrossRef
45.
go back to reference Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-8.PubMedCrossRef Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-8.PubMedCrossRef
46.
go back to reference Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.PubMedCrossRef Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008;88:1009-86.PubMedCrossRef
47.
go back to reference Kushwaha SS, Narula J, Narula N, et al. Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. Am J Cardiol 1998;82:1377-81.PubMedCrossRef Kushwaha SS, Narula J, Narula N, et al. Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. Am J Cardiol 1998;82:1377-81.PubMedCrossRef
48.
go back to reference Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.PubMedCrossRef Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.PubMedCrossRef
49.
go back to reference Neumann T, Heusch G. Myocardial, skeletal muscle, and renal blood flow during exercise in conscious dogs with heart failure. Am J Physiol 1997;273:H2452-7.PubMed Neumann T, Heusch G. Myocardial, skeletal muscle, and renal blood flow during exercise in conscious dogs with heart failure. Am J Physiol 1997;273:H2452-7.PubMed
50.
go back to reference Blankstein R, Shturman LD, Rogers IS, et al. Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol 2009;54:1072-84.PubMedCrossRef Blankstein R, Shturman LD, Rogers IS, et al. Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol 2009;54:1072-84.PubMedCrossRef
51.
go back to reference Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.PubMedCrossRef Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.PubMedCrossRef
52.
go back to reference Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.PubMedCrossRef Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.PubMedCrossRef
53.
go back to reference Herzog BA, Husmann L, Valenta I, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMedCrossRef Herzog BA, Husmann L, Valenta I, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMedCrossRef
54.
go back to reference Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation 2009;119:e561-87.PubMedCrossRef Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation 2009;119:e561-87.PubMedCrossRef
55.
go back to reference Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992;85:883-92.PubMedCrossRef Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992;85:883-92.PubMedCrossRef
56.
57.
go back to reference Galiuto L, Sestito A, Barchetta S, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol 2007;99:1378-83.PubMedCrossRef Galiuto L, Sestito A, Barchetta S, et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol 2007;99:1378-83.PubMedCrossRef
58.
go back to reference Lee MS, Kobashigawa J, Tobis J. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy. JACC Cardiovasc Interv 2008;1:710-5.PubMedCrossRef Lee MS, Kobashigawa J, Tobis J. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy. JACC Cardiovasc Interv 2008;1:710-5.PubMedCrossRef
59.
go back to reference Kobashigawa J. Cardiac allograft vasculopathy: Background and recent advances. Johns Hopkins Advanced Studies in Medicine: Proceedings 2008;8:189-95. Kobashigawa J. Cardiac allograft vasculopathy: Background and recent advances. Johns Hopkins Advanced Studies in Medicine: Proceedings 2008;8:189-95.
60.
go back to reference Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997;336:1208-15.PubMedCrossRef Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997;336:1208-15.PubMedCrossRef
61.
go back to reference Wolford TL, Donohue TJ, Bach RG, et al. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries. Circulation 1999;99:626-32.PubMedCrossRef Wolford TL, Donohue TJ, Bach RG, et al. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries. Circulation 1999;99:626-32.PubMedCrossRef
Metadata
Title
PET measurement of adenosine stimulated absolute myocardial blood flow for physiological assessment of the coronary circulation
Author
Henry Gewirtz, MD
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 2/2012
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-011-9510-9

Other articles of this Issue 2/2012

Journal of Nuclear Cardiology 2/2012 Go to the issue

ASNC Calendar

ASNC Calendar